ERIK CROOK: Open Payments
NPI 1659449544 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 45 payments from 17 companies in 2025. Trend: 2023 $718 · 2024 $940 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $137 |
| Novo Nordisk Inc | 6 | $96 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| PFIZER INC. | 3 | $68 |
| Lilly USA, LLC | 4 | $68 |
| ABBVIE INC. | 4 | $67 |
| Amgen Inc. | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $44 |
| Zimmer Biomet Holdings, Inc. | 1 | $38 |
| Exact Sciences Corporation | 2 | $32 |
Products named: FARXIGA, LEQVIO, JARDIANCE, Wegovy, Ozempic, MOUNJARO, XIFAXAN, PREVNAR 20.
Industry payments across SC — which companies pay providers there.
